UAB Pulmonary, Allergy, and Critical Care Medicine

UAB Pulmonary, Allergy, and Critical Care Medicine The UAB Pulmonary Disease and Critical Care Medicine Training Program is a unique blend of excellent clinical training and novel laboratory research.

The UAB Division of Pulmonary, Allergy, and Critical Care Medicine Fellowship Program delivers world-class clinical training and top-tier academic opportunities, and state-of-the-art medical treatment. Our program provides a rich and supportive educational environment where life-long learning skills are acquired and intellectual curiosity is treasured. We take pride in the regular recognition of o

ur faculty and fellows as outstanding teachers, clinicians and researchers. This program aims to:
(1) produce physicians who are clinically competent in Pulmonary Disease and Critical Care Medicine; highly effective in a variety of clinical settings; and possess habits of life-long learning to allow for continued growth in knowledge, skills and other aspects of a professional career in Academic Pulmonary and Critical Care Medicine;
(2) produce physicians that understand the indications and are competent in the performance of invasive and non-invasive procedures related to Pulmonary Disease and Critical Care Medicine; and
(3) produce physicians that are well-versed in the methodology required for the implementation, analysis, and reporting of quality improvement processes as well as hypothesis-driven research projects. Our Division has a long history of providing excellent training in Pulmonary Disease and Critical Care Medicine. Our program's primary mission is to assist you in achieving your personal professional goals while acquiring the skills, attitudes and knowledge to function as a pulmonary and critical care physician in the setting of your choice. Pulmonary and Critical Care Medicine is a discipline that embraces a unique blend of medical knowledge, advanced technology and deep concern for the human element of our patients and profession. Of all the ingredients that have allowed our Division to be so successful in this field, clearly the most important is the high quality of the individuals we have been fortunate to have as faculty, fellows and staff. We are very happy that you have taken the time to study our program and hope you find the information available to be valuable.

The final presentation for the will be Jessy Deshane, PhD discussing Spatial Resolution of Response to Combination Imm...
11/02/2024

The final presentation for the will be Jessy Deshane, PhD discussing Spatial Resolution of Response to Combination Immunotherapy for NSCL!

Scott S. Oh, DO, FCCP, delivers his keynote speech on upcoming bronchoscopic therapies at the !Watch this speech and al...
11/02/2024

Scott S. Oh, DO, FCCP, delivers his keynote speech on upcoming bronchoscopic therapies at the !

Watch this speech and all of the via Zoom!
https://t.co/tQVTRcceWL

The update moves to a panel discussion, providing perspectives on care from patients, nurses, physicians, and social w...
11/02/2024

The update moves to a panel discussion, providing perspectives on care from patients, nurses, physicians, and social workers.

Watch this panel and all of the via Zoom!
https://t.co/tQVTRcceWL

The with Aakash Desai, MD providing updated information on clinical trials!
11/02/2024

The with Aakash Desai, MD providing updated information on clinical trials!

Next up at the is Padma Manapragada, MD, covering Peptide Receptor Radionuclide Therapy in Pulmonary Neuroendocrine Tu...
11/02/2024

Next up at the is Padma Manapragada, MD, covering Peptide Receptor Radionuclide Therapy in Pulmonary Neuroendocrine Tumors!

The continues with Maya Khalil, MD discussing targeted therapies.
11/02/2024

The continues with
Maya Khalil, MD discussing targeted therapies.

Day Two of the continues with Benjamin Wei, MD covering complex airway reconstruction.
11/02/2024

Day Two of the continues with Benjamin Wei, MD covering complex airway reconstruction.

Day Two of the has begun with an opening speech from Hitesh Batra. "Our goal should be - No one dies of lung cancer."
11/02/2024

Day Two of the has begun with an opening speech from Hitesh Batra.


"Our goal should be - No one dies of lung cancer."

We are in the middle of an outstanding key ote address from Annabelle Gurwitch !
11/02/2024

We are in the middle of an outstanding key ote address from Annabelle Gurwitch !

Everyone gear up for the first night of the ! Annabelle Gurwitch will be speaking!
11/01/2024

Everyone gear up for the first night of the !
Annabelle Gurwitch will be speaking!

08/22/2024

The Center for Lung Analytics and Imaging Research (CLAIR) will launch at UAB this year to improve diagnosis and monitoring for patients with chronic lung disease. The center brings together experts from nine scientific specialties who will work to establish new methods for lung imaging and other di...

UAB Medicine is conducting a study called the “Randomized Trial of Sedative Choice for Intubation” (RSI) to learn whethe...
07/03/2024

UAB Medicine is conducting a study called the “Randomized Trial of Sedative Choice for Intubation” (RSI) to learn whether, for seriously ill patients who need a breathing machine, ketamine or etomidate is a better sedative medication with regards to blood pressure, oxygen levels, and heart function.

For patients being placed on a breathing machine in the UAB Medicine emergency department or intensive care unit:

-When the doctors feel ketamine would be best, the doctors give the patients ketamine
-When the doctors feel that etomidate would be best, the doctors give the patient etomidate
-When they do not have a preference, the patient participates in the RSI study and is assigned either ketamine or etomidate randomly. This means every patient has a fair and equal chance of getting either drug.

Both drugs are commonly used to place patients on a breathing machine. Both are approved by the FDA.

To learn more about the study, visit the study website at www.pragmaticcriticalcare.org/RSI.

Address

1900 University Boulevard Tinsley Harrison Tower, Suite 422
Birmingham, AL
35294

Telephone

+12059344328

Website

Alerts

Be the first to know and let us send you an email when UAB Pulmonary, Allergy, and Critical Care Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The University

Send a message to UAB Pulmonary, Allergy, and Critical Care Medicine:

Shortcuts

Share

Category